2024-05-10 04:54:04 ET
Summary
- Balchem Corporation's Q1 2024 earnings surpassed expectations, but the company's full-year bottom-line expansion could be slower than what it achieved for the first quarter.
- The Human Nutrition & Health segment is riding on the supplements market's growth, while the Animal Nutrition & Health segment is encountering stiff competition in the European animal feed market.
- It is a tale of two businesses for BCPC, which implies that the stock warrants a Neutral or Hold rating.
Elevator Pitch
I award a Hold investment rating to Balchem Corporation ( BCPC ). My earlier update written on February 21, 2024 reviewed the company's Q4 2023 results....
Read the full article on Seeking Alpha
For further details see:
Balchem: A Tale Of Two Businesses